• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correlations between serum inflammation factors and left ventricular remodeling in acute ST segment elevation myocardial infarction.血清炎症因子与急性 ST 段抬高型心肌梗死患者左心室重构的相关性研究。
Yonsei Med J. 2012 May;53(3):501-7. doi: 10.3349/ymj.2012.53.3.501.
2
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者血清白细胞介素-6、可溶性CD40配体、金属蛋白酶-9及金属蛋白酶组织抑制剂-1升高的临床意义
Clin Cardiol. 2008 Sep;31(9):413-8. doi: 10.1002/clc.20254.
3
Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者3年随访期间白细胞介素-6的预后价值
Heart Vessels. 2009 Sep;24(5):329-34. doi: 10.1007/s00380-008-1128-8. Epub 2009 Sep 27.
4
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者血清白细胞介素-6、可溶性CD40配体、金属蛋白酶-9及金属蛋白酶组织抑制剂-1升高的临床意义
Clin Cardiol. 2009 May;32(5):288. doi: 10.1002/clc.20464.
5
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.血浆组织金属蛋白酶抑制剂-1 和基质金属蛋白酶-9:急性心肌梗死后左心室重构和预后的新指标。
Eur Heart J. 2008 Sep;29(17):2116-24. doi: 10.1093/eurheartj/ehn315. Epub 2008 Jul 8.
6
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy.急性ST段抬高型心肌梗死患者中的基质金属蛋白酶-9及其调节因子金属蛋白酶组织抑制因子-1和细胞外基质金属蛋白酶诱导因子:一项北欧非ST段抬高型心肌梗死亚研究
Cardiology. 2018;139(1):17-24. doi: 10.1159/000481684. Epub 2017 Nov 16.
7
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.血浆基质金属蛋白酶-9与人类急性心肌梗死后左心室重构:一项前瞻性队列研究。
Eur Heart J. 2007 Mar;28(6):711-8. doi: 10.1093/eurheartj/ehm003. Epub 2007 Mar 5.
8
Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.外周循环 CD14+单核细胞中基质金属蛋白酶 9/金属蛋白酶组织抑制剂 1 比值与冠状动脉疾病进展的关系。
Am J Cardiol. 2010 Feb 15;105(4):429-34. doi: 10.1016/j.amjcard.2009.10.013. Epub 2010 Jan 5.
9
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.急性心肌梗死后人体血浆基质金属蛋白酶-9和基质金属蛋白酶-2:与左心室功能障碍的超声心动图及神经体液参数的相关性
J Card Fail. 2004 Aug;10(4):328-33. doi: 10.1016/j.cardfail.2003.11.003.
10
Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction.早期测量血浆基质金属蛋白酶-2 可预测 ST 段抬高型心肌梗死的梗死面积和心室功能障碍。
Heart. 2012 Jan;98(1):31-6. doi: 10.1136/heartjnl-2011-300079. Epub 2011 Jul 4.

引用本文的文献

1
Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy.降低ST段抬高型心肌梗死期间的心脏损伤:多靶点治疗策略的合理方法
J Clin Med. 2021 Jul 1;10(13):2968. doi: 10.3390/jcm10132968.
2
Regulation mechanism of aquaporin 9 gene on inflammatory response and cardiac function in rats with myocardial infarction through extracellular signal-regulated kinase1/2 pathway.水通道蛋白9基因通过细胞外信号调节激酶1/2通路对心肌梗死大鼠炎症反应和心功能的调控机制
Heart Vessels. 2019 Dec;34(12):2041-2051. doi: 10.1007/s00380-019-01452-8. Epub 2019 Jun 19.
3
Gambogic acid exerts cardioprotective effects in a rat model of acute myocardial infarction through inhibition of inflammation, iNOS and NF-κB/p38 pathway.藤黄酸通过抑制炎症、诱导型一氧化氮合酶(iNOS)以及核因子κB(NF-κB)/p38信号通路,对急性心肌梗死大鼠模型发挥心脏保护作用。
Exp Ther Med. 2018 Feb;15(2):1742-1748. doi: 10.3892/etm.2017.5599. Epub 2017 Dec 5.
4
Insights of Chinese medicine on ventricular remodeling: Multiple-targets, individualized-treatment.中医对心室重构的认识:多靶点、个体化治疗。
Chin J Integr Med. 2017 Sep;23(9):643-647. doi: 10.1007/s11655-017-2415-y. Epub 2017 Sep 2.
5
Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.阿托伐他汀通过干扰胶原代谢改善心肌梗死后的心室重构。
PLoS One. 2016 Nov 23;11(11):e0166845. doi: 10.1371/journal.pone.0166845. eCollection 2016.
6
Adiponectin-resistin index and its strong association with acute coronary syndrome in South Indian men.脂联素-抵抗素指数及其与南印度男性急性冠状动脉综合征的强关联。
Inflamm Res. 2014 Nov;63(11):961-8. doi: 10.1007/s00011-014-0771-z. Epub 2014 Sep 14.

本文引用的文献

1
Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both.曲拉普利、缬沙坦或两者联合治疗急性心肌梗死后基质金属蛋白酶-9 水平的变化与左心室重构有关。
Circ J. 2010 Jun;74(6):1158-64. doi: 10.1253/circj.cj-09-0412. Epub 2010 Apr 6.
2
Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者血清白细胞介素-6、可溶性CD40配体、金属蛋白酶-9及金属蛋白酶组织抑制剂-1升高的临床意义
Clin Cardiol. 2008 Sep;31(9):413-8. doi: 10.1002/clc.20254.
3
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.血浆组织金属蛋白酶抑制剂-1 和基质金属蛋白酶-9:急性心肌梗死后左心室重构和预后的新指标。
Eur Heart J. 2008 Sep;29(17):2116-24. doi: 10.1093/eurheartj/ehn315. Epub 2008 Jul 8.
4
Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.循环基质溶解素-1(基质金属蛋白酶-3):急性心肌梗死后左心室功能障碍、重塑及全因死亡率的新型预测指标。
Eur J Heart Fail. 2008 Feb;10(2):133-9. doi: 10.1016/j.ejheart.2007.12.009. Epub 2008 Jan 30.
5
Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.健康受试者、糖尿病患者及急性冠状动脉综合征患者中金属蛋白酶-2和-9的比较。
Heart Vessels. 2007 Nov;22(6):361-70. doi: 10.1007/s00380-007-0989-6. Epub 2007 Nov 26.
6
Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes.稳定型和不稳定型冠状动脉综合征患者中细胞因子与可溶性CD40配体之间的相互作用。
Eur J Clin Invest. 2007 Aug;37(8):623-8. doi: 10.1111/j.1365-2362.2007.01834.x.
7
Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome.在急性冠状动脉综合征中,白细胞介素-6和基质金属蛋白酶-9水平升高源于心脏。
Scand Cardiovasc J. 2007 Jun;41(3):149-54. doi: 10.1080/14017430601164263.
8
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.血浆基质金属蛋白酶-9与人类急性心肌梗死后左心室重构:一项前瞻性队列研究。
Eur Heart J. 2007 Mar;28(6):711-8. doi: 10.1093/eurheartj/ehm003. Epub 2007 Mar 5.
9
Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling.心肌梗死后患者体内基质金属蛋白酶释放具有特定的时间模式:与左心室重构的关系。
Circulation. 2006 Sep 5;114(10):1020-7. doi: 10.1161/CIRCULATIONAHA.105.600353. Epub 2006 Aug 21.
10
Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome.
Int J Cardiol. 2007 Feb 14;115(3):361-5. doi: 10.1016/j.ijcard.2006.03.019. Epub 2006 Aug 1.

血清炎症因子与急性 ST 段抬高型心肌梗死患者左心室重构的相关性研究。

Correlations between serum inflammation factors and left ventricular remodeling in acute ST segment elevation myocardial infarction.

机构信息

Department of Cardiology, Xuanwu Hospital, Capital Medical University, NO 45 Changchun Ave, Xuanwu district, Beijing 100053, PR China.

出版信息

Yonsei Med J. 2012 May;53(3):501-7. doi: 10.3349/ymj.2012.53.3.501.

DOI:10.3349/ymj.2012.53.3.501
PMID:22476992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3343422/
Abstract

PURPOSE

To investigate the changes and correlations of the serum inflammation factors levels and left ventricular (LV) structure and function in patients with acute ST segment elevation myocardial infarction (STEMI).

MATERIALS AND METHODS

A prospective study was performed on 70 STEMI patients and 70 control subjects. Serum levels of interleukin-6 (IL-6), soluble CD40 ligand (sCD40L), metalloproteinase- 9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were measured by sandwich enzyme-linked immunosorbent assay (ELISA), and cardiac structure and function were assessed by echocardiography at admission and 3-year follow-up.

RESULTS

We found that the levels of serum IL-6, sCD40L and MMP-9 increased steadily among control subjects, remote myocardial infarction and acute STEMI patients, and the level of TIMP-1 elevated remarkly at 3-year follow-up visit in STEMI. The admission level of serum MMP-9 positively correlated with LV end-diastolic and end-diastole volume (r=0.294, p=0.022; r=0.269, p=0.036, respectively), and TIMP-1 positively correlated with E/A ratio (r=0.278, p=0.044) at 3-year follow-up.

CONCLUSION

The study indicates that admission levels of serum MMP-9 and TIMP-1 closely correlated with left ventricular structure and function, which may be involved in the process of post-infarction remodeling of myocardium.

摘要

目的

研究急性 ST 段抬高型心肌梗死(STEMI)患者血清炎症因子水平的变化及其与左心室(LV)结构和功能的相关性。

材料和方法

对 70 例 STEMI 患者和 70 例对照者进行前瞻性研究。采用夹心酶联免疫吸附试验(ELISA)检测血清白细胞介素-6(IL-6)、可溶性 CD40 配体(sCD40L)、基质金属蛋白酶-9(MMP-9)和基质金属蛋白酶组织抑制剂-1(TIMP-1)水平,入院时和 3 年后通过超声心动图评估心脏结构和功能。

结果

我们发现,在对照组、陈旧性心肌梗死和急性 STEMI 患者中,血清 IL-6、sCD40L 和 MMP-9 水平持续升高,而 TIMP-1 水平在 STEMI 患者 3 年随访时显著升高。入院时血清 MMP-9 水平与 LV 舒张末期和舒张末期容积呈正相关(r=0.294,p=0.022;r=0.269,p=0.036),而 TIMP-1 水平与 3 年后随访时的 E/A 比值呈正相关(r=0.278,p=0.044)。

结论

本研究表明,入院时血清 MMP-9 和 TIMP-1 水平与左心室结构和功能密切相关,可能参与心肌梗死后的重构过程。